About Medexus
Medexus is a Healthcare company based in Mississauga (Canada) founded in 2000, and was acquired by Medexus Pharmaceuticals in September 2018. It develops specialty pharmaceuticals for rare diseases and healthcare needs. It operates on a B2B model. Its website medexus.ca draws about 681 thousand monthly visits. Medexus offers products and services including Trecondyv, GRAFAPEX, and Gleolan. Its focus areas include Biotechnology, Therapeutics, Oncology Treatments and Pharmaceuticals. Its legal entity is Medexus Pharmaceuticals, Inc.
Company details
Medexus Pharmaceuticals is a specialty pharmaceutical company that develops and markets products for diseases including allergy, dermatology, hematology, oncology, and rheumatology, with a focus on rare conditions. It operates through a fully integrated infrastructure covering commercial operations, supply chain, regulatory affairs, and medical services in North America. Based in Toronto, Canada, the company serves patients and healthcare professionals via partnerships and direct distribution, emphasizing quality and innovation in its portfolio.
- Headquarters Mississauga, Canada
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website medexus.ca
- Social LinkedIn X Facebook
- Acquired by Medexus Pharmaceuticals (Sep 2018)
- Legal Name Medexus Pharmaceuticals, Inc.
- Investors
- Acquired byMedexus Pharmaceuticals
(Sep 2018)
Products & Services of Medexus
Medexus offers a comprehensive portfolio of products and services, including Trecondyv, GRAFAPEX, and Gleolan.
Injection for treating certain cancers in rare disease contexts
Used for specific hematology and oncology applications
Aids in oncology treatments for rare conditions
Investors in Medexus
Medexus has secured backing from 1 investor. Prominent investors backing the company include Medexus Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Pharmaceutical drugs are manufactured for rheumatology, immunology, and oncology sectors. | 2004 | medexus.com | Montreal, Canada |
Investor details for Medexus
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Medexus
2 dated milestones of Medexus across 18 years, from founding to its latest funding, stage changes and deals.
- Founded Medexus is founded.
- Exit Acquired by Medexus Pharmaceuticals.
Web traffic of Medexus
The website of Medexus (medexus.ca) receives about 680.7K visits a month.
- Monthly visits680.7K
▼ 6.7% vs previous month
Websites whose visitors overlap most with Medexus. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| falconebiz.com | 100% | 959.8K | #63,970 | View details | |
| tofler.in | 97% | 556K | #105,509 | View details | |
| zaubacorp.com | 96% | 4.9M | #12,689 | View details | |
| tracxn.com | 92% | 2.9M | #16,597 | View details | |
| indiafilings.com | 90% | 2.1M | #29,959 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Medexus
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Medexus
Complete news archive for Medexus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medexus
Medexus was founded in 2000.
Medexus is headquartered in Mississauga, Canada. It is registered at Mississauga, Ontario, Canada.
Medexus Pharmaceuticals is a specialty pharmaceutical company that develops and markets products for diseases including allergy, dermatology, hematology, oncology, and rheumatology, with a focus on rare conditions. It operates through a fully integrated infrastructure covering commercial operations, supply chain, regulatory affairs, and medical services in North America. Based in Toronto, Canada, the company serves patients and healthcare professionals via partnerships and direct distribution, emphasizing quality and innovation in its portfolio.
Medexus offers Trecondyv, GRAFAPEX, and Gleolan.
Medexus has 1 investor. Key investors include Medexus Pharmaceuticals.
Medexus operates through Medexus Pharmaceuticals, Inc..
Yes. Medexus was acquired by Medexus Pharmaceuticals in September 2018.
The website of Medexus receives about 681 thousand visits a month.